Results 61 to 70 of about 624,402 (215)

Pathologic Finding of Thymic Carcinoma Accompanied by Myasthenia Gravis [PDF]

, 2015
BACKGROUND AND PURPOSE: The World Health Organization (WHO) has classified thymic carcinoma and other thymomas (types A, AB, and B) as different neoplasms.
김세훈
core   +1 more source

Challenges and Pitfalls to Diagnosing NUTM1‐Rearranged Neoplasia of the Pancreas by Cytology and Ancillary Studies

Diagnostic Cytopathology, EarlyView.
ABSTRACT Fine‐needle aspiration cytology specimens are frequently utilized for ancillary studies to identify diagnostic and prognostic information. This case highlights diagnostic pitfalls and challenges in diagnosing NUTM1‐rearranged neoplasia on pancreatic cytology.
Terrance J. Lynn
wiley   +1 more source

Perspective of Immune Checkpoint Inhibitors in Thymic Carcinoma

, 2021
Thymic carcinoma is a rare neoplasm with a dismal prognosis, and there are no established therapeutic regimens for metastatic or recurrent disease. Immune checkpoint inhibitors (ICIs), such as PD-1/PD-L1 antibodies, are widely approved in several human ...
Hisao Imai, Hiroshi Kagamu, Kyoichi Kaira   +2 more
core   +1 more source

Successful Use of Pembrolizumab to Treat Refractory Thymic Carcinoma with High PD-L1 Expression

Case Reports in Oncology, 2018
Thymic carcinoma is a relatively rare and aggressive thymic epithelial tumor. Herein, we report successful treatment of thymic carcinoma with pembrolizumab. A 68-year-old woman was admitted to our hospital for evaluation of chest pain.
Takuma Isshiki, Kazutoshi Isobe, Naobumi Tochigi, Motoko Sunakawa, Yasuhiko Nakamura, Kazutoshi Shibuya, Susumu Sakamoto, Yujiro Takai, Sakae Homma   +8 more
doaj   +1 more source

Human biomarker navigator

iMeta, EarlyView.
The Human Biomarker Navigator integrates the disease continuum, biomarker dynamics, cross‐organ biomarker networks, biomarker classification, and technology‐driven paradigms. It maps how biomarkers link multi‐system physiology and pathology across the nervous, respiratory, endocrine, circulatory, immune, digestive, urinary, reproductive, and ...
Meng‐Yao Li, Qian Zhang, Zijie Wang, Zeping Gui, Jing Liu, Jingda Li, Maojun Jiang, Zukang Chang, Qingqing Han, Bendong Yang, Tariq Saeed, Jun Li, Jinghan Jia, Chenghu Song, Tong Shao, Tianhuan Peng, Xueying Zhang, Pingping Guo, Jun Luo, Gangao Yang, Yuan Wan, Gokhan Zengin, Quan Yuan, Lingru Li, Xiaohui Fan, Yang Luo, Lvyun Zhu, Yanfei Zheng, Wenjun Mao, Wenlong Sun   +29 more
wiley   +1 more source

A spontaneous reduction in tumor size of a thymic carcinoma: a case report

Surgical Case Reports, 2022
Background Spontaneous regression of thymic carcinoma is extremely rare. We report a case of a resected thymic carcinoma with preoperative spontaneous regression in a 67-year-old woman.
Shoei Kuroki, Takanori Ayabe, Hiroyuki Tanaka, Hiroshi Nakada, Ryo Maeda   +4 more
doaj   +1 more source

Heterogeneity Analyzed by CT‐Based Habitat Analysis for Clinical Management of Cancers: A Narrative Review

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Tumors are highly heterogeneous, and whole‐lesion radiomics analysis is a popular method for extracting texture features that reflect this heterogeneity, which can be used to build models for cancer diagnosis, staging, therapy response evaluation, and prognosis prediction.
Yang Zhang, Zhi‐Yan Jin, Min‐Ying Lydia Su   +2 more
wiley   +1 more source

Trophoblast Cell Surface Antigen 2 Expression in Thymic Carcinoma: Brief Report

JTO Clinical and Research Reports
Introduction: Trophoblast cell surface antigen 2 (TROP2) is a transmembrane glycoprotein overexpressed in various cancer types. Although TROP2-targeting therapy is currently attracting attention, little is known about TROP2 expression in thymic carcinoma.
Kana Kurokawa, MD, PhD, Tetsuhiko Asao, MD, PhD, Takuo Hayashi, MD, PhD, Satsuki Kishikawa, MD, PhD, Koichiro Kanamori, MD, PhD, Takehito Shukuya, MD, PhD, Yosuke Miyashita, MD, Ikuko Nakamura, MD, PhD, Taichi Miyawaki, MD, PhD, Ryota Kanemaru, MD, PhD, Tomoyasu Mimori, MD, PhD, Yoichiro Mitsuishi, MD, PhD, Ken Tajima, MD, PhD, Naoko Shimada, MD, PhD, Fumiyuki Takahashi, MD, PhD, Kazuya Takamochi, MD, PhD, Kenji Suzuki, MD, PhD, Kazuhisa Takahashi, MD, PhD   +17 more
doaj   +1 more source

Data‐Independent Acquisition Mass Spectrometry in Tumor Classification and Cancer Biomarker Research

Mass Spectrometry Reviews, EarlyView.
Abstract Cancer treatment is far from optimal also because current classification systems do not reflect the complex molecular status of the tumor and its phenotype in sufficient detail. To construct molecular tumor classifiers, omics tools provide complex molecular data reflecting many aspects from genotype to phenotype.
Jan Simonik, Petr Lapcik, Pavla Bouchalova, Pavel Bouchal   +3 more
wiley   +1 more source

Thymic Carcinoma Associated with Cerebellar Degeneration [PDF]

, 2017
We present the case of a 57-year-old man with ataxia and clinical and radiological features of cerebellar degeneration. A computed tomography showed a mediastinal mass. The patient was diagnosed of thymic carcinoma. paraneoplastic cerebellar degeneration
Rodríguez Galdeano, Mónica, Julián Solís García del Pozo, Irene García Cuartero, Mónica Rodríguez Galdeano, Montserrat Pérez Pinar, García del Pozo, Julián Solís, García Cuartero, Irene, Pérez Pinar, Montserrat   +7 more
core   +1 more source